维普中文期刊产品整合服务
24篇 您的检索式:作者名="FELIPE H"
    题名 作者 年代 出处 被引量
1Immunotherapy for de novo renal transplantation :what's in the pipeline? 显示文摘TEDESCO SILVA H JR PINHEIRO MACHADO P ROSSO FELIPE C 2006Drugs2006,66,13:1
2Seroprevalence and national distribution of human toxoplasmosis in Mexico: analysis of the 2000 and 2006 National Health Surveys显示文摘Heriberto Caballero-Ortega Felipe Javier Uribe-Salas Carlos J. Conde-Glez Carlos Cedillo-Pelaez José Antonio Vargas-Villavicencio Héctor Luna-Pastén Irma Ca?edo-Solares Luz Belinda Ortiz-Alegría Dolores Correa 2012Transactions of the Royal Society of Tropical Medicine and Hygiene2012,,11:1
3Wireless sensor network deployment for integrating video-surveillance anddata- monitoring in precision agriculture over distributed crops 显示文摘ANTONIO J G S FELIPE G S JOAN G H 2011Computers and Electronics in Agriculture2011,75,:1
4Wireless sensor network deployment for integrating video-surveillance and data-monitoring in precision agriculture over distributed crops显示文摘Antonio J G S Felipe G S Joan G H 2011Computers and Electronics in Agriculture2011,,75:1
5Pharmacogenetics of calcineurin inhibitors in Brazil ian renal transplant patients显示文摘Santoro A Felipe CR Tedesco-Silva H 2011Pharmacogenom ics2011,12,9:1
6Growth, feed efficiency and condition of common Octopus fed two formulated moist diets显示文摘Jesus C V Maria D H Felipe A G 2008Aquaculture2008,275,:1
7Synthesis and anti-inflammatory activity of chalcone derivativs显示文摘FELIPE H LUISA F M AMALIA U 1998Bioorganic & Medicinal Chemistry Letters1998,8,:1
8The C-terminal tetrapeptide of phaseolin is sufficient to target green flurescent protein to the vacuole显示文摘Frigerio L Foresti O Felipe D H 2001J Plant Physiol2001,158,:1
9Supporting Local Adaptation:The Contribution of Socio-environ- mental Fragmentation to Urban Vulnerability显示文摘Kerstin K Felipe L Juliane W Jordan H Katrin B Felipe I 2014Applied Geography2014,55,12:1
10Anaerobic codigestion of municipal, farm, and industrial organic waste: a survey of recent literature显示文摘Felipe A M Parviz S Hub H J C 2006Water Environment Research2006,78,6:1
11The implications of megatrends in information and communication technology and transportation for changes in global physical activity显示文摘Michael Pratt Olga L Sarmiento Felipe Montes David Ogilvie Bess H Marcus Lilian G Perez Ross C Brownson 20122012 (9838)2012,,9838:1
12Y-TZP ceramic processing from co- precipitated powders: a comparative study with three commercial dental ceramics 显示文摘Laza Dolores R R Bottino Marco C Mutlu Ozcan Luiz Felipe Valandro Regina Amaral Valter Ussui Ana H A Bressiani 2008Dental Materials2008,24,1:1
13Long-termeffect of microbial abundance and humus-associatedenzyme activities under semiarid conditions显示文摘Felipe B Ellen K Teresa H Carlos García 2008MedSciEntry for Microbial Ecology2008,55,65:1
14Case study: Risk analysis by overtopping of diversion works during dam construction: The La Yesca hydroelectric project, Mexico 显示文摘Marengo H Felipe I A Aldama A 2013Structural Safety2013,42,:1
15Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer显示文摘Patients with early-stage non-small-cell lung cancer(NSCLC)are candidates for curative surgery;however,despite multiple advances in lung cancer management,recurrence rates remain high.Adjuvant chemotherapy has been demonstrated to significantly prolong overall survival(OS),but this benefit is modest and there is an urgent need for effective new therapies to provide a cure for more patients.The high efficacy of tyrosine kinase inhibitors(TKIs)against epidermal growth factor receptor-mutated(EGFR)in patients with advanced EGFR-mutated NSCLC has led to the evaluation of these agents in early stages of the disease.Multiple clinical trials have evaluated the safety and efficacy of EGFR TKIs as an adjuvant treatment,in patients with resected EGFR-mutated NSCLC,and shown that they significantly prolong disease-free survival(DFS),but this benefit does not translate to OS.Recently,an interim analysis of the ADAURA trial demonstrated that,surprisingly,osimertinib improved DFS.This led to the study being stopped early,leaving many unanswered questions about its potential effect on OS and its incorporation as a standard adjuvant treatment in this patient subgroup.These targeted agents are also being evaluated in locally-advanced disease,with promising results,although prospective studies with larger sample sizes are needed to confirm these results.In this article,we review the most relevant studies on the role of EGFR TKIs in the management of early-stage EGFR-mutated NSCLC.Miguel J Sotelo Jose Luis García Cesar Torres-Mattos Héctor Milián Carlos Carracedo María Angeles González-Ruiz Xabier Mielgo-Rubio Juan Carlos Trujillo-Reyes Felipe Couñago 2021World Journal of Clinical Oncology2021,12,10:1
16The multiple meanings of open govern-ment data : understanding different stakeholders and their perspectives显示文摘FELIPE G Z RICHARD H 2015Government information quarterly2015,32,4:1
17Optical spectrum of MoS2:many-body effects and diversity of exciton states显示文摘QIU D FELIPE H LOUIE S 2013Physical Review Letters2013,111,21:1
18The effect of a minor constituent of essential oil from Citrus aurantium : The role of β-myrcene in preventing peptic ulcer disease显示文摘Flavia Bonamin Thiago M. Moraes Raquel C. dos Santos Hélio Kushima Felipe M. Faria Marcos A. Silva Ivan V. Junior Leonardo Nogueira Tais M. Bauab Alba R.M. Souza Brito Lucia R.M. da Rocha Clélia A. Hiruma-Lima 2014Chemico-Biological Interactions2014,,:1
19Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial显示文摘Michael Wang Luis Fayad Nicolaus Wagner-Bartak Liang Zhang Fredrick Hagemeister Sattva S Neelapu Felipe Samaniego Peter McLaughlin Michelle Fanale Anas Younes Fernando Cabanillas Nathan Fowler Kate J Newberry Luhong Sun Ken H Young Richard Champlin Larry 2012Lancet Oncology2012,,:1
20Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients 显示文摘SANTORO A FELIPE C R TEDESCO-SILVA H 2011Pharmacogenomics2011,12,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费